Simple blood test and brain game could spot Alzheimer's years earlier
NCT ID NCT07466394
First seen Mar 16, 2026 · Last updated May 12, 2026 · Updated 7 times
Summary
This study aims to improve how doctors detect early signs of Alzheimer's disease in people aged 60 and older. Researchers will provide general practitioners and specialists with digital cognitive tests and blood-based biomarkers to identify individuals with mild cognitive decline. The goal is to create a practical system for early diagnosis, which is key for future treatments. The study will enroll 400 participants in Germany.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER'S DISEASE (AD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Klinik für Psychiatrie und Psychotherapie am LMU Klinikum
RECRUITINGMünchen, 80336, Germany
Conditions
Explore the condition pages connected to this study.